1
|
Liao K, Gao Y, Cheng M, Zhang Y, Zhao J, Zhou L, Wu R, Cai G, Cao L, Chen J, Lin Y. Intranasal delivery of AEP inhibitor-loaded neuron-targeted liposome ameliorates radiation-induced brain injury. Mater Today Bio 2025; 31:101568. [PMID: 40026629 PMCID: PMC11872414 DOI: 10.1016/j.mtbio.2025.101568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2024] [Revised: 12/31/2024] [Accepted: 02/08/2025] [Indexed: 03/05/2025] Open
Abstract
Acute exposure to high-dose radiation during head and neck tumors radiotherapy can result in radiation-induced brain injury (RIBI), characterized by neurocognitive deficits, dementia, and epilepsy. Asparagine endopeptidase (AEP), a cysteine proteinase, is effective in preventing neurodegenerative diseases and RIBI. However, the limited permeability of selective AEP inhibitor (AEPI) delivery to the brain reduces its effectiveness in preventing RIBI. This study constructed a nose-to-brain delivery platform for AEPI by encapsulating it in liposomes that are surface modified with rabies virus glycoprotein (RVG29), creating RVG29-AEPI liposomes. These RVG29-AEPI liposomes demonstrated efficient cellular uptake and blood-brain barrier penetration in vitro and in vivo. RVG29-AEPI liposomes effectively shielded DNA from radiation-induced damage and resulted in more effective reactive oxygen species removal than liposomes in primary neurons and microglial cells. Notably, the treatment with RVG29-AEPI liposomes (10 mg/kg AEPI) was highly systemically safe and significantly reduced brain injury. Behavioral tests demonstrated that RVG29-AEPI liposomes-treated mice had less radiation-induced brain damage and motor dysfunction. Moreover, it significantly prevented neuronal injury and microglia cell activation under photon and modern proton irradiation. These findings demonstrate the potential of nose-to-brain medication delivery of RVG29-AEPI liposomes for effective radioprotection, indicating a viable technique with enormous potential for clinical translation.
Collapse
Affiliation(s)
- Keman Liao
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China
- Institute for Medical Imaging Technology, Shanghai, 201800, China
| | - Yan Gao
- Department of Neurosurgery, Jiangnan University Medical Center, 214000, China
- Wuxi neurosurgical Institute, Jiangsu, 214000, China
| | - Mengdan Cheng
- Department of Neurosurgery, Jiangnan University Medical Center, 214000, China
- Wuxi neurosurgical Institute, Jiangsu, 214000, China
| | - Yibing Zhang
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China
- Institute for Medical Imaging Technology, Shanghai, 201800, China
| | - Jianyi Zhao
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China
- Institute for Medical Imaging Technology, Shanghai, 201800, China
| | - Li Zhou
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China
- Institute for Medical Imaging Technology, Shanghai, 201800, China
| | - Ran Wu
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China
- Institute for Medical Imaging Technology, Shanghai, 201800, China
| | - Gang Cai
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China
- Institute for Medical Imaging Technology, Shanghai, 201800, China
| | - Lu Cao
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China
- Institute for Medical Imaging Technology, Shanghai, 201800, China
| | - Jiayi Chen
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China
- Institute for Medical Imaging Technology, Shanghai, 201800, China
| | - Yingying Lin
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China
- Institute for Medical Imaging Technology, Shanghai, 201800, China
| |
Collapse
|
2
|
Nascimento Júnior JAC, Santos AM, Oliveira AMS, Santos AB, de Souza Araújo AA, Aragón DM, Frank LA, Serafini MR. The Tiny Big Difference: Nanotechnology in Photoprotective Innovations - A Systematic Review. AAPS PharmSciTech 2024; 25:212. [PMID: 39242428 DOI: 10.1208/s12249-024-02925-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2024] [Accepted: 08/18/2024] [Indexed: 09/09/2024] Open
Abstract
UV radiation causes long- and short-term skin damage, such as erythema and skin cancer. Therefore, the use of sunscreens is extremely important. However, concerns about UV filter safety have prompted exploration into alternative solutions, with nanotechnology emerging as a promising avenue. This systematic review identified 23 experimental studies utilizing nanocarriers to encapsulate sunscreens with the aim of enhancing their efficacy and safety. Polymeric and lipid nanoparticles are frequently employed to encapsulate both organic and inorganic UV filters along with natural antioxidants. Nanocarriers have demonstrated benefits including reduced active ingredient usage, increased sun protection factor, and mitigated photoinstability. Notably, they also decreased the skin absorption of UV filters. In summary, nanocarriers represent a viable strategy for improving sunscreen formulations, offering enhanced physicochemical properties and bolstered photoprotective effects, thereby addressing concerns regarding UV filter safety and efficacy in cosmetic applications.
Collapse
Affiliation(s)
| | | | - Ana Maria Santos Oliveira
- Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Brazil
| | | | - Adriano Antunes de Souza Araújo
- Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Brazil
- Postgraduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Brazil
- Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil
| | - Diana Marcela Aragón
- Departamento de Farmacia, Facultad de Ciencias, Universidad Nacional da Colombia, Bogotá, D.C, Colombia
| | - Luiza Abrahão Frank
- Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Sul, Porto Alegre, Brazil
- Núcleo de Terapias Nanotecnológicas (NTnano), Federal University of Rio Grande Do Sul, Porto Alegre, Brazil
| | - Mairim Russo Serafini
- Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Brazil.
- Postgraduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Brazil.
- Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil.
| |
Collapse
|